Novartis financials at a glance

+ Portfolio

The revenue of Novartis is reported as 45.44 billion Switzerland Francs in the fiscal year 2023. The earnings were 6.47 Switzerland Francs per share in 2023, which was 5.72 higher than 2022. And about 13.398 billion Switzerland Francs are reported as free cash flow in the financials of Novartis 2023. Dividends of 3.82 Switzerland Francs per share were paid to shareholders of Novartis stock SWX:NOVN in fiscal 2023.

CHF45.44B

Revenue

CHF6.47

Earnings Per Share

74.24%

Gross Margin %

CHF12.95B

Free Cash Flow

Revenue

45,440.00

Earnings Per Share

6.47

Gross Margin %

74.24

Free Cash Flow

12,953.20

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Rev.	Revenue	N/A	CHF45.44B	CHF50.55B	CHF51.63B	CHF48.66B	CHF47.45B	CHF51.90B	CHF49.11B	CHF48.52B	CHF49.41B	CHF58.00B	CHF57.92B	CHF56.67B	CHF58.57B	CHF50.62B	CHF44.27B	CHF41.46B	CHF39.80B	CHF37.02B	CHF32.21B	CHF28.25B
GM %	Gross Margin %	71.27%	74.24%	70.90%	70.81%	71.14%	70.37%	68.52%	69.09%	64.89%	65.46%	67.66%	68.63%	70.01%	68.72%	72.64%	72.87%	73.28%	72.77%	73.19%	75.00%	75.44%
OM	Operating Margin	29.83%	27.09%	24.81%	22.78%	24.42%	18.67%	19.36%	20.61%	18.40%	17.82%	20.68%	21.76%	23.83%	21.50%	24.91%	23.12%	22.14%	21.08%	21.88%	23.15%	22.61%
EPS	Earnings Per Share	CHF3.72	CHF6.47	CHF6.12	CHF6.29	CHF5.78	CHF5.28	CHF5.15	CHF4.86	CHF4.75	CHF4.93	CHF5.23	CHF5.09	CHF5.25	CHF5.57	CHF5.11	CHF4.49	CHF4.08	CHF3.24	CHF3.15	CHF2.73	CHF2.34
Div.	Dividends	N/A	CHF3.82	CHF3.50	CHF3.36	CHF3.38	CHF3.02	CHF2.85	CHF2.97	CHF2.75	CHF2.65	CHF2.88	CHF2.74	CHF2.48	CHF2.42	CHF2.37	CHF2.02	CHF1.76	CHF1.46	CHF1.08	CHF0.90	CHF1.06
PR %	Payout Ratio %	0	59.04%	57.19%	53.42%	58.48%	57.20%	55.34%	61.11%	57.89%	53.75%	55.07%	53.83%	47.24%	43.45%	46.38%	44.99%	43.14%	45.06%	34.29%	32.97%	45.30%
Sha.	Shares	N/AM	2,044.03M	2,119.61M	2,234.94M	2,256.82M	2,265.01M	2,311.17M	2,317.46M	2,374.06M	2,373.89M	2,398.63M	2,426.08M	2,420.62M	2,406.69M	2,289.45M	2,274.35M	2,264.85M	2,264.45M	2,348.23M	2,335.92M	2,426.81M
OCF	Operating Cash Flow	N/A	CHF14.46B	CHF14.24B	CHF15.07B	CHF13.65B	CHF13.63B	CHF14.27B	CHF12.62B	CHF11.48B	CHF11.90B	CHF13.90B	CHF13.17B	CHF14.19B	CHF14.31B	CHF14.07B	CHF12.19B	CHF9.77B	CHF9.21B	CHF8.71B	CHF0.00M	CHF0.00M
FCF	Free Cash Flow	N/A	CHF12.95B	CHF11.95B	CHF13.28B	CHF11.69B	CHF12.88B	CHF11.72B	CHF10.43B	CHF9.46B	CHF9.03B	CHF10.76B	CHF9.95B	CHF11.38B	CHF12.50B	CHF12.35B	CHF10.30B	CHF7.66B	CHF6.66B	CHF6.93B	CHF0.00M	CHF0.00M
FCFS	Free Cash Flow Per Share	CHF6.89	CHF6.58	CHF5.39	CHF5.73	CHF5.03	CHF5.39	CHF5.37	CHF4.68	CHF3.97	CHF3.75	CHF4.43	CHF4.05	CHF4.77	CHF5.27	CHF5.42	CHF4.19	CHF3.32	CHF5.95	CHF2.83	CHF2.85	CHF2.10

Novartis financials at a glance

Financials

Discover